The Navigation Model of Therapy: Why Awareness Changes Everything
November 16, 2025
Brand Name :
Draximage Gluceptate
Synonyms :
technetium Tc-99m gluceptate
Class :
Radiopharmaceutical
Dosage Forms & StrengthsÂ
Kit, IntravenousÂ
25 mg/vial Â
Dose of 0.03 mL/kg intravenously administered 10 to 30 minutes before 15 to 25 mCi of sodium pertechnetate Tc 99m
Administer dose of 15 to 20 mCi intravenously
not determined Â
Refer to adult dosingÂ
Actions and SpectrumÂ
The uptake of technectium Tc-99m gluceptate by the kidneys allows for the visualization and assessment of renal function and blood flow. The radioactive decay of Tc-99m results in the emission of gamma rays.Â
Frequency defined Â
<1%Â
ErythemaÂ
DyspneaÂ
Skin rash Â
Vomiting Â
Allergic dermatitis Â
Nausea Â
Flushing Â
Hypersensitivity Â
Pruritus
Black Box WarningÂ
None
Contraindication/Caution:Â
Contraindication:Â
None Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: technetium Tc 99m is excreted into human breast milkÂ
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
technetium Tc-99m gluceptate acts as a chelating agent that binds to Tc-99m, forming a stable complex. Â
The Tc-99m gluceptate complex is then preferentially taken up by the kidneys, where it is filtered by the glomeruli and excreted into the renal tubules. Â
PharmacodynamicsÂ
technectium Tc-99m gluceptate complex emits gamma radiation as Tc-99m undergoes radioactive decay. Â
The emitted gamma rays are used to create images that depict the distribution of the radiopharmaceutical in the body.Â
PharmacokineticsÂ
Absorption  Â
technetium Tc-99m gluceptate is rapidly enters the bloodstream after intravenous administration. Â
DistributionÂ
technectium Tc-99m gluceptate circulates throughout the body.Â
MetabolismÂ
technetium Tc-99m gluceptate is not significantly metabolized in the body. Â
Elimination and excretionÂ
technectium Tc-99m gluceptate is primarily eliminated from the body through the urinary system.Â
AdministrationÂ
technetium Tc-99m gluceptate is typically administered intravenously as an injection into the bloodstream.Â
Patient information leafletÂ
Generic Name: technetium Tc-99m gluceptateÂ
Why do we use technetium Tc-99m gluceptate?Â
technetium Tc-99m gluceptate used as brain imaging agent for evaluation of brain perfusion. Â
technetium Tc-99m gluceptate used as kidney imaging agent for evaluation of renal perfusion. Â
technetium Tc-99m gluceptate used as cardiac blood pool imaging agent.Â